Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Budesonide versus Prednisolone as Primary Treatment for Autoimmune Hepatitis
2018-003381-14Phase 4Terminated
- Sponsor
- Umeå University Hospital
- Start
- Dec 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in autoimmune hepatitis (AIH) comparing Budesonide primary therapy with Prednisolone primary therapy (2 arms). Primary endpoint: Complete laboratory remission of autoimmune hepatitis. Started Dec 2019; status: terminated.
02
Drugs
budesonideprednisolone
03
Conditions
autoimmune hepatitis (AIH)
Beyond the preview
Go deeper on 2018-003381-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-003381-14.